Hemispherx BioPharma, Inc. (AMEX:HEB)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Recs

0
Player Avatar redwings103149 (59.17) Submitted: 8/24/2009 6:09:10 PM : Outperform Start Price: $2.14 HEB Score: -115.63

Under heavy accumulation by barclays and other major players who know alot more than we do. Time to jump on baby

Featured Broker Partners


Advertisement